Steven Cohen’s Kazia Therapeutics KZIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.3M Sell
200,000
-300
-0.1% -$3.76K ﹤0.01% 2328
2026
Q2
$2.3M Buy
200,300
+300
+0.2% +$3.66K ﹤0.01% 2295
2026
Q1
$1.49M Hold
200,000
– – ﹤0.01% 2506
2025
Q4
$1.38M Buy
+200,000
New +$1.7M ﹤0.01% 2696

Other funds holding KZIA

Steven Cohen's KZIA Position: Q3 2026 in Review

Steven Cohen reduced its Kazia Therapeutics (KZIA) stake by 0.15% in Q3 2026, selling an estimated $3.76K and leaving 200,000 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Steven Cohen first reported a position in KZIA in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.3M in Q2 2026. 55 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.

  • Steven Cohen held 200,000 shares of Kazia Therapeutics worth $2.3M as of Q3 2026.
  • Steven Cohen sold 300 Kazia Therapeutics shares in Q3 2026, an estimated $3.76K.
  • Kazia Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2328 holding.
  • Steven Cohen first reported a position in Kazia Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Steven Cohen's Kazia Therapeutics position peaked at $2.3M in Q2 2026.
  • 55 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.